Clinical Trials Logo

Filter by:
NCT ID: NCT00321620 Completed - Bone Metastases Clinical Trials

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer

Start date: April 1, 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if denosumab is non-inferior to zoledronic acid (Zometa®) in the treatment of bone metastases in men with hormone-refractory prostate cancer

NCT ID: NCT00333801 Completed - Clinical trials for Posttraumatic Stress Disorder (PTSD)

The Impact of Vocational Rehabilitation on Mentally III Veterans

Start date: April 1, 2006
Phase: N/A
Study type: Interventional

To study the impact of Individual Placement and Support (IPS) supported employment (SE) compared to treatment-as-usual vocational rehabilitation program (VRP) for veterans with posttraumatic stress disorder (PTSD).

NCT ID: NCT00349310 Completed - Depression Clinical Trials

Profile of Depressive Symptoms in Parkinsons Disease

Start date: April 1, 2006
Phase:
Study type: Observational

To explore or establish the relationship between cognitive, mood and motor symptoms in PD to scores on depression rating scales in a naturalistic setting.

NCT ID: NCT00392561 Completed - Clinical trials for Non-melanoma Skin Cancer

Bangladesh Vitamin E and Selenium Trial

BEST
Start date: April 1, 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate whether selenium and/or vitamin E are effective in preventing non-melanoma skin cancers.

NCT ID: NCT00456573 Completed - Clinical trials for Obstructive Sleep Apnea Syndrome

Cytokine Profiles in Children With Obstructive Sleep Apnea

Start date: April 1, 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the cytokine profile of tonsillar and peripheral blood mononuclear cells in patients with obstructive sleep apnea (OSA) and to compare the blood mononuclear cell cytokine secretion profile between patients with obstructive sleep apnea and controls without apnea.

NCT ID: NCT00463554 Completed - Clinical trials for Stress Urinary Incontinence

TVT-SECUR A Pilot Study for the Treatment of Stress Urinary Incontinence

Start date: April 1, 2006
Phase:
Study type: Observational

The primary objective of this study is to obtain clinical performance information on the GYNECARE TVT-SECUR* System (Tension-free Support for Incontinence) in women with stress urinary incontinence (SUI).

NCT ID: NCT00494793 Completed - Open Abdomen Clinical Trials

Vacuum Assisted Wound Closure (VAWC) and Mesh Mediated Fascial Traction

Start date: April 1, 2006
Phase: N/A
Study type: Interventional

The purpose of this multicenter trial is to prospectively evaluate a novel combination of vacuum assisted wound closure (VAWC) and mesh mediated fascial traction for closure of open abdomens.

NCT ID: NCT00503178 Completed - Bone Metastases Clinical Trials

Biological Imaging Guided Antalgic Radiotherapy of Bone Metastases (Phase II Trial)

Start date: April 1, 2006
Phase: Phase 2
Study type: Interventional

Highly selective irradiation requires accurate target definition by high-resolution three-dimensional imaging. Co-registration of FDG-PET and high-resolution CT might be the imaging modality of choice. This choice might target radiation therapy precisely to the intra-osseous volume that is responsible for pain and to spare selectively healthy bone in the vicinity of the metastasis. This strategy could result in equal anti-pain efficacy as conventional large volume radiotherapy, but could allow bone remodeling and preservation of bone structural strength in the vicinity and could lead to reduced toxicity to neighboring organs.

NCT ID: NCT00606450 Completed - Psoriasis Clinical Trials

Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis

PSOR-003
Start date: April 1, 2006
Phase: Phase 2
Study type: Interventional

There is an unmet medical need for safe, effective oral therapy for moderate-to-severe psoriasis. CC-10004 will be evaluated in a controlled setting of a clinical study. The information obtained from the study will aid in the design of future clinical trials and to establish the safety and efficacy of CC-10004.

NCT ID: NCT00695825 Completed - Clinical trials for Metabolic Syndrome X

Effects the Glycemic Index on Metabolic Risk Markers

Start date: April 1, 2006
Phase: N/A
Study type: Interventional

Recent population studies have shown that the glycemic index (GI) of food products is positively associated with the risk of developing type 2 diabetes and cardiovascular disease (CVD). In the pathogenesis of type 2 diabetes and CVD, inflammatory processes play a pivotal role. In a previous intervention study (11 weeks), however, we found no effects of lower-GI vs. higher-GI diets on fasting inflammatory markers in subjects with increased risk of developing the metabolic syndrome. People, however, spent most of their time in the postprandial period. Therefore, there is a need to study the postprandial effects of low-GI vs. high-GI diets. In addition, it needs to be emphasized the GI is derived from studies in lean subjects, while especially overweight and obese people suffer from metabolic aberrations related to the development of type 2 diabetes and CVD. AIM: To investigate in obese subjects the postprandial effects of a low-GI vs. high-GI food product on metabolic risk markers. A second research objective is to compare these effects with those in lean subjects.